Quick Answer
Solid Biosciences Inc. reported Shares Outstanding of 78.97 million shares for fiscal year 2025.
Solid Biosciences Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 78.97M | +95.1% |
| 2024 | 40.47M | +98.5% |
| 2023 | 20.39M | +4.2% |
| 2022 | 19.56M | +165.9% |
| 2021 | 7.36M | -91.3% |
| 2020 | 84.89M | +84.6% |
| 2019 | 45.99M | +29.8% |
| 2018 | 35.43M | — |
| 2017 | 0 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 77.88M | +100.1% | +0.4% |
| June 30, 2025 | 77.60M | +101.3% | +0.1% |
| March 31, 2025 | 77.49M | +104.8% | +91.5% |
| December 31, 2024 | 40.47M | +98.5% | +4.0% |
| September 30, 2024 | 38.93M | +94.1% | +1.0% |
| June 30, 2024 | 38.55M | +92.3% | +1.9% |
| March 31, 2024 | 37.83M | +93.3% | +85.6% |
| December 31, 2023 | 20.39M | +4.2% | +1.6% |
- Solid Biosciences Inc. showed an increase of +95.1% in Shares Outstanding compared to the prior fiscal year.
- The most recent figure is from Solid Biosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: